Skip to main content

Crucell Gets Wyeth Orders

The orders will start benefiting its business in 2007.

Vaccine maker

Crucell

undefined

said it received its first contract manufacturing orders from

Scroll to Continue

TheStreet Recommends

Wyeth's

(WYE)

biotech group.

Crucell expects the orders to start benefiting its business in 2007.

Shares of Crucell gained 40 cents, or 1.6%, to $25.06.